Posted on 10/3/17
Celgene Could Be A $200 Stock
Since its spin-off from Celanese in 1986, Celgene (CELG) has built an active pipeline of drugs that focus on treatments for cancer and inflammatory diseases. Additionally, . . .
Posted on 6/28/17
PTC Therapeutics: The Star Is Rising
IntroductionPTC Therapeutics (PTCT) is a pharmaceutical company with expertise in Ribonucleic acid biology. The company has strategic collaborations with Roche and SMA Foundation for spinal muscular . . .
Pittsburgh
